Group One Trading, L.P. Harvard Bioscience Inc Transaction History
Group One Trading, L.P.
- $2.54 Billion
- Q4 2024
A detailed history of Group One Trading, L.P. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 200 shares of HBIO stock, worth $236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$236% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding HBIO
# of Institutions
97Shares Held
31.3MCall Options Held
0Put Options Held
15K-
Black Rock Inc. New York, NY2.84MShares$3.36 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.76MShares$3.25 Million0.35% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$3.17 Million0.66% of portfolio
-
Amh Equity LTD2.5MShares$2.95 Million5.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$2.55 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $49.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...